Cargando…
Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling
Pulmonary arterial hypertension (PAH) is a rare disease characterized by high blood pressure in the pulmonary circulation driven by pathological remodeling of distal pulmonary arteries, leading typically to death by right ventricular failure. Available treatments improve physical activity and slow d...
Autores principales: | Andre, Patrick, Joshi, Sachindra R., Briscoe, Steven D., Alexander, Mark J., Li, Gang, Kumar, Ravindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818880/ https://www.ncbi.nlm.nih.gov/pubmed/35141256 http://dx.doi.org/10.3389/fmed.2021.814222 |
Ejemplares similares
-
Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure
por: Joshi, Sachindra R., et al.
Publicado: (2023) -
Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension
por: Joshi, Sachindra R., et al.
Publicado: (2022) -
TGFβ superfamily signaling and uterine decidualization
por: Ni, Nan, et al.
Publicado: (2017) -
The Role of the TGF-β Superfamily in Myocardial Infarction
por: Hanna, Anis, et al.
Publicado: (2019) -
Sex-biased TGFβ signalling in pulmonary arterial hypertension
por: Wits, Marius, et al.
Publicado: (2023)